Widely-noted research published recently indicated that the presence of chemicals like BPA and methylparaben can interfere with commonly-used breast cancer therapies. On October 27, 2011 this call featured the lead author of that study, William Goodson, MD as well as Mhel Kavanaugh-Lynch, MD, MPH, who discussed health policy opportunities based on this research and other studies associating chemical exposures with breast cancer.
Ted Schettler, MD, MPH also provided a brief update on new science relevant to this topic.
This call was co-sponsored by CHE's Breast Cancer Working Group.
The call was facilitated by Steve Heilig, San Francisco Medical Society.